| Dr Pedro Antonio Pacheco Maldonado, MD | |
|
Road 985 Km 4.1 (box 5323), Bo. Florencio, Fajardo, PR 00738 | |
| (787) 863-5882 | |
| (787) 863-1114 |
| Full Name | Dr Pedro Antonio Pacheco Maldonado |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | Road 985 Km 4.1 (box 5323), Fajardo, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326037698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 13468 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pedro Antonio Pacheco Maldonado, MD Hc 66 Box 5323, Fajardo, PR 00738-9606 Ph: (787) 863-5882 | Dr Pedro Antonio Pacheco Maldonado, MD Road 985 Km 4.1 (box 5323), Bo. Florencio, Fajardo, PR 00738 Ph: (787) 863-5882 |
News Archive
The advanced neovascular, or "wet," form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study, published in the online version of the journal Ophthalmology, suggest that monthly injections of ranibizumab improve eye chart test results required for a driver's license, build driver confidence and keep those with AMD driving longer.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
By capturing movies of both the blood and vasculature of zebrafish embryos, each less than two millimeters long, researchers have been able for the first time to see the very moment that blood begins to flow.
› Verified 9 days ago
Mr. Ignacio Hernandez Fragoso, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: B St C-7 Urb Melendez, Fajardo, PR 00738 Phone: 787-860-7448 |